These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15640949)

  • 1. Semi-quantitative RT-PCR assessment of molecular markers in breast large-core needle biopsies.
    Pohlodek K; Galbavý S; Bartosová M; Mucha V; Holomán K; Pastorek J; Pastoreková S
    Neoplasma; 2004; 51(6):415-21. PubMed ID: 15640949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do prognostic marker studies on core needle biopsy specimens of breast carcinoma accurately reflect the marker status of the tumor?
    Jacobs TW; Siziopikou KP; Prioleau JE; Raza S; Baum JK; Hayes DF; Schnitt SJ
    Mod Pathol; 1998 Mar; 11(3):259-64. PubMed ID: 9521472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accurately assessing her-2/neu status in needle core biopsies of breast cancer patients in the era of neoadjuvant therapy: emerging questions and considerations addressed.
    D'Alfonso T; Liu YF; Monni S; Rosen PP; Shin SJ
    Am J Surg Pathol; 2010 Apr; 34(4):575-81. PubMed ID: 20216378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
    Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
    Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical specimen can be replaced by core samples in assessment of ER, PR and HER-2 for invasive breast cancer.
    Sutela A; Vanninen R; Sudah M; Berg M; Kiviniemi V; Rummukainen J; Kataja V; Kärjä V
    Acta Oncol; 2008; 47(1):38-46. PubMed ID: 17851859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biopathologic profile of breast cancer core biopsy: is it always a valid method?
    Cavaliere A; Sidoni A; Scheibel M; Bellezza G; Brachelente G; Vitali R; Bucciarelli E
    Cancer Lett; 2005 Jan; 218(1):117-21. PubMed ID: 15639347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative profiling of symptomatic breast cancer by diagnostic core biopsy.
    Cahill RA; Walsh D; Landers RJ; Watson RG
    Ann Surg Oncol; 2006 Jan; 13(1):45-51. PubMed ID: 16378157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Core needle biopsy as a diagnostic tool to differentiate phyllodes tumor from fibroadenoma.
    Komenaka IK; El-Tamer M; Pile-Spellman E; Hibshoosh H
    Arch Surg; 2003 Sep; 138(9):987-90. PubMed ID: 12963656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection.
    Pinzani P; Salvadori B; Simi L; Bianchi S; Distante V; Cataliotti L; Pazzagli M; Orlando C
    Hum Pathol; 2006 Jun; 37(6):711-8. PubMed ID: 16733212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative polymerase chain reaction analysis of c-myc amplification on archival breast fine-needle aspiration materials.
    Rao JY; Apple SK; Jin Y; Lin S; Nieberg RK; Hirtschowitz SL
    Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):175-9. PubMed ID: 10698478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunohistochemical determination of hormonal receptors on cell-blocks from fine-needle cytopunctures of breast carcinoma].
    Briffod M; Le Doussal V; Spyratos F
    Bull Cancer; 2001 Oct; 88(10):1028-35. PubMed ID: 11713039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometry: a new approach for the molecular profiling of breast cancer.
    Lostumbo A; Mehta D; Setty S; Nunez R
    Exp Mol Pathol; 2006 Feb; 80(1):46-53. PubMed ID: 16271361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative assessment of proliferative activity and hormonal receptor status in carcinoma of the breast: a comparison of needle aspiration and needle-core biopsies to the surgical specimen.
    Railo M; Nordling S; Krogerus L; Sioris T; von Smitten K
    Diagn Cytopathol; 1996 Sep; 15(3):205-10. PubMed ID: 8955602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of HER2 and the coamplified genes GRB7 and MLN64 in human breast cancer: quantitative real-time reverse transcription-PCR as a diagnostic alternative to immunohistochemistry and fluorescence in situ hybridization.
    Vinatzer U; Dampier B; Streubel B; Pacher M; Seewald MJ; Stratowa C; Kaserer K; Schreiber M
    Clin Cancer Res; 2005 Dec; 11(23):8348-57. PubMed ID: 16322295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.
    Esteva FJ; Sahin AA; Cristofanilli M; Coombes K; Lee SJ; Baker J; Cronin M; Walker M; Watson D; Shak S; Hortobagyi GN
    Clin Cancer Res; 2005 May; 11(9):3315-9. PubMed ID: 15867229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of a panel of mRNA markers in the detection of disseminated tumor cells in patients with operable breast cancer.
    Varangot M; Barrios E; Sóñora C; Aizen B; Pressa C; Estrugo R; Lavigna R; Musé I; Osinaga E; Berois N
    Oncol Rep; 2005 Aug; 14(2):537-45. PubMed ID: 16012742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do the histologic features and results of breast cancer biomarker studies differ between core biopsy and surgical excision specimens?
    Burge CN; Chang HR; Apple SK
    Breast; 2006 Apr; 15(2):167-72. PubMed ID: 16095904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative RT-PCR detection of tumor cells in sentinel lymph nodes isolated from colon cancer patients with an ex vivo approach.
    Nordgård O; Oltedal S; Kørner H; Aasprong OG; Tjensvoll K; Gilje B; Heikkilä R
    Ann Surg; 2009 Apr; 249(4):602-7. PubMed ID: 19300229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large-core needle biopsy versus fine-needle aspiration biopsy in solid breast lesions: comparison of costs and diagnostic value.
    Vimpeli SM; Saarenmaa I; Huhtala H; Soimakallio S
    Acta Radiol; 2008 Oct; 49(8):863-9. PubMed ID: 18618302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.